• Изучение чувствительности Atopobium vaginae к деквалиния хлориду
To content

Изучение чувствительности Atopobium vaginae к деквалиния хлориду

HEALTH OF WOMAN. 2016.2(108):60– 62


Изучение чувствительности Atopobium vaginae к деквалиния хлориду


Guido Lopes dos Santos Santiago, Grob Philipp, Verstraelen Hans, Waser Florian, Vaneechoutte Mario

Laboratory Bacteriology Research, Faculty Medicine & Health Sciences, University of Ghent, De Pintelaan 185, Ghent 9000, Belgium

Medinova AG, Eggbuehlstrasse 14, Zurich 8052, Switzerland

Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences,

Ghent University, De Pintelaan 185, Ghent, Belgium

BMC Research Notes 2012, 5:151


Литература: 
1. Hillier SL, Holmes KK, Marrazzo JM. 2008. Bacterial vaginosis. In Sexually transmitted diseases. 4 edition. Edited by: Holmes KK. New York: McGraw-Hill: 737-68.

2. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, De Ganck C, Temmerman M, Vaneechoutte M. 2004. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 4:16. http://dx.doi.org/10.1186/1471-2180-4-16; PMid:15102329 PMCid:PMC419343

3. Verstraelen H, Verhelst R. 2009. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect Ther 7:1109-1124. http://dx.doi.org/10.1586/eri.09.87; PMid:19883331

4. Workowski KA, Berman SM. 2006. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 55(RR-11):1-94. PMid:16888612

5. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193:1478-1486. http://dx.doi.org/10.1086/503780; PMid:16652274

6. Larsson PG, Forsum U. 2005. Bacterial vaginosis-a disturbed bacterial flora and treatment enigma. APMIS 113:305-316. http://dx.doi.org/10.1111/j.1600-0463.2005.apm_113501.x

7. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. 2004. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191(4):1124-1129. http://dx.doi.org/10.1016/j.ajog.2004.05.033; PMid:15507930

8. De Backer E, Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Temmerman M, Vaneechoutte M. 2006. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis 6:51. http://dx.doi.org/10.1186/1471-2334-6-51; PMid:16542416 PMCid:PMC1468414

9. Bradshaw CS, Tabrizi SN, Fairley CK, Morton AN, Rudland E, Garland SM. 2006. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 194:828-836. http://dx.doi.org/10.1086/506621; PMid:16941351

10. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. 2004. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4:5. http://dx.doi.org/10.1186/1471-2334-4-5; PMid:15018635 PMCid:PMC362875

11. Della Casa V, Noll H, Gonser S, Grob P, Graf F, Pohlig G. 2002. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections. Arzneimitte-lforschung 52:699-705. PMid:12404886

12. Strecker M, Kokemohr H, Teucher T, Schmitz H. 1993. Antiseptika gegen vulvovaginitiden. TW Gynдkologie 6:409-412.

13. Petersen EE, Weissenbacher ER, Hengst P, Spitzbart H, Weise W, Wolff F, Dreher E, Ernst U, Della Casa V, Pohlig G, Graf F, Kaiser RR. 2002. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimittelforschung 52:706-715. PMid:12404887

14. Weissenbacher ER, Donders G, Unzeitig V, Martinez de Tejada B, Gerber S, Halaљka M, Љpaљek J, Fluomizin Study Group. A comparison of dequalinium chloride vaginal tablets (fluomizin) and clindamycin vaginal cream in treatment of bacterial vaginosis: single blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest.

15. De Backer E, Dubreuil L, Brauman M, Acar J, Vaneechoutte M. 2010. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin Microbiol Infect 16:470-472. http://dx.doi.org/10.1111/j.1469-0691.2009.02852.x; PMid:19548924

16. Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG: Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD Surveillance Study. Antimicrob Agents Chemother.